Annual Financial Report - Correction

Summary by AI ^BETAClose X

BSF Enterprise PLC has issued a correction to its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025, revising the net loss from £1,013,527 to £1,113,527, an increase of £100,000. This adjustment impacts both the RNS Highlights and the Financial Summary on page 6 of the report.

Disclaimer*

BSF Enterprise PLC

03 February 2026

3 February 2026

BSF Enterprise PLC

("BSF" or the "Company")

Annual Report and Accounts - Correction

BSF Enterprise PLC (LSE: BSFA), a leading innovator in tissue-engineered materials, advises in relation to its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025 released yesterday, that there is a correction to the RNS Highlights and on page 6 of the report in the first paragraph of the Financial Summary where the net loss of £1,013,527 should be £1,113,527.

The Annual Report is available to view on the Company's website at: https://bsfenterprise.com/reports-documents-and-presentations#reports

BSF Enterprise PLC

Geoff Baker - Chairman

Che Connon - CEO & Director

Shard Capital (Broker)

Damon Heath

Isabella Pierre

0207 186 9000

0207 186 9927

AlbR Capital Limited (Broker)

Colin Rowbury

Jon Belliss

+44 (0)20 7469 0930

ISIN of the Ordinary Shares

is GB00BHNBDQ51.

SEDOL Code is BHNBDQ5.

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END